Moderna files RSV vaccine for older adults in US and Europe
Moderna said Wednesday that it started a rolling submission to the FDA for its RSV vaccine in adults 60 years and older as it aims …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
